SELLAS Life Sciences Group, Inc. SLS Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s stock issuance proceeds?
- SELLAS Life Sciences Group, Inc. (SLS) reported stock issuance proceeds of $66K in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s stock issuance proceeds changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s stock issuance proceeds increased by 37.5% year-over-year, from $48K to $66K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s stock issuance proceeds?
- Over 2 years (2021 to 2024), SELLAS Life Sciences Group, Inc.'s stock issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $9.01M to $0.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.